314 related articles for article (PubMed ID: 29979235)
1. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Werntz RP; Pearce SM; Eggener SE
Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235
[TBL] [Abstract][Full Text] [Related]
2. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
[TBL] [Abstract][Full Text] [Related]
3. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
4. Robotic-assisted retroperitoneal lymph node dissection for testicular cancer.
Gereta S; Hung M; Hu JC
Curr Opin Urol; 2023 Jul; 33(4):274-280. PubMed ID: 37014761
[TBL] [Abstract][Full Text] [Related]
5. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
9. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
Bhayani SB; Allaf ME; Kavoussi LR
Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
[TBL] [Abstract][Full Text] [Related]
12. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
13. Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience.
Kamel MH; Littlejohn N; Cox M; Eltahawy EA; Davis R
J Endourol; 2016 May; 30(5):510-9. PubMed ID: 26669219
[TBL] [Abstract][Full Text] [Related]
14. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
[TBL] [Abstract][Full Text] [Related]
15. Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer.
Nason GJ; Kuhathaas K; Anson-Cartwright L; Jewett MAS; O'Malley M; Sweet J; Hansen A; Bedard P; Chung P; Hahn E; Warde P; Hamilton RJ
J Robot Surg; 2022 Apr; 16(2):369-375. PubMed ID: 33982173
[TBL] [Abstract][Full Text] [Related]
16. Utilization of robotics for retroperitoneal lymph-node dissection in pediatric and non-pediatric hospitals.
Brown CT; Sebastião YV; Zann A; McLeod DJ; DaJusta D
J Robot Surg; 2020 Dec; 14(6):865-870. PubMed ID: 32200542
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.
Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G
J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537
[TBL] [Abstract][Full Text] [Related]
18. Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience.
Nason GJ; Hamilton RJ
World J Urol; 2022 Feb; 40(2):335-342. PubMed ID: 34988650
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
[TBL] [Abstract][Full Text] [Related]
20. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]